The store will not work correctly when cookies are disabled.
4-(Aminomethyl)-8-(4-tert-butylphenyl)-1,5-naphthyridine
ID: ALA2413357
PubChem CID: 71817834
Max Phase: Preclinical
Molecular Formula: C19H21N3
Molecular Weight: 291.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1ccc(-c2ccnc3c(CN)ccnc23)cc1
Standard InChI: InChI=1S/C19H21N3/c1-19(2,3)15-6-4-13(5-7-15)16-9-11-21-17-14(12-20)8-10-22-18(16)17/h4-11H,12,20H2,1-3H3
Standard InChI Key: DGEAZXRBXSBNAH-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
18.3646 -14.7328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3635 -15.5602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0783 -15.9730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0764 -14.3201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7918 -14.7291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7926 -15.5560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5078 -15.9669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.2229 -15.5522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2181 -14.7223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5023 -14.3150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4973 -13.4952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2112 -13.0795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2072 -12.2553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4900 -11.8458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7754 -12.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7830 -13.0894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0802 -16.7980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3667 -17.2122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4845 -11.0209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1962 -10.6036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7674 -10.6131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4785 -10.1955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
10 11 1 0
3 17 1 0
17 18 1 0
14 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 291.40 | Molecular Weight (Monoisotopic): 291.1735 | AlogP: 4.05 | #Rotatable Bonds: 2 |
Polar Surface Area: 51.80 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.13 | CX LogP: 3.62 | CX LogD: 1.90 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.77 | Np Likeness Score: -0.52 |
References
1. Parhi AK, Zhang Y, Saionz KW, Pradhan P, Kaul M, Trivedi K, Pilch DS, LaVoie EJ.. (2013) Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines., 23 (17): [PMID:23891185] [10.1016/j.bmcl.2013.06.048] |